27

February 27, 2015

MiRNA-based therapy for cancer: MiRNA-100 suppresses the expression of RNA polymerase I via down regulation of its target gene, 27/February/2015, 23.36

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for cancer: MiRNA-100 suppresses the expression of RNA polymerase I via down regulation of its […]
February 27, 2015

Regulation of NFKB signalling: Neurotensin suppresses the expression of TNFAIP3, the negative regulator of NFKB, via down regulation of its target gene, 27/February/2015, 23.22

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Regulation of NFKB signalling: Neurotensin  suppresses the expression of TNFAIP3, the negative regulator of NFKB, via […]
February 27, 2015

MiRNA-based anti-tumor immunity enhancement therapy: MiRNA-128-2 promotes anti-tumor immunity via down regulation of its target gene, 27/February/2015, 23.02

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based anti-tumor immunity enhancement therapy: MiRNA-128-2 promotes anti-tumor immunity via down regulation of its target gene, […]
February 27, 2015

MiRNA-based therapy for Melonama: MiRNA-203 increases the expression of ADAR1 and inhibits melanoma progression via down regulation of its target gene, 27/February/2015, 09.10 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Melonama:  MiRNA-203 increases the expression of ADAR1 and inhibits melanoma progression via down […]